View Press Releases
-
CD Formulation Introduces Microneedle Patch Innovations for Enhanced Drug Delivery Efficiency
-
Alfa Chemistry Expands Offering of Polymer Fibers: Polyester Fiber, Polyamide Fiber, Aromatic Polyamide Fiber, and Polyacrylonitrile Fiber
-
New Study Links Patients with Multiple Phenotypes to Higher Body Weight and BMI
Research from Mayo Clinic published in Nature’s International Journal of Obesity introduces new insights into obesity precision medicine for patients with more than one phenotype.
Mar 13, 2024
-
Phreesia Announces Jack Callahan as New Chief Technology Officer
Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer.
Mar 20, 2024
-
ENPICOM secures financing from BOP Capital, BOM Brabant Ventures and brings Dr. Colby Souders on board as a new investor
Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery
Mar 20, 2024
-
Alfa Chemistry's MS and NMR Center Enables Fast, Cost-Effective Laboratory Analytical Testing
-
ResultsCX Named ‘Promising Provider’ in Everest Group’s Service Provider Compass™ – Global Services Delivery from Mexico Report
-
CD Formulation Incorporates Phase Separation Method for Microsphere Production
-
ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemophilia patients with inhibitors
ReciBioPharm partners with GeneVentiv Therapeutics to advance first AAV-based gene therapy for haemophilia patients
Mar 19, 2024
-
Hovione and GEA Strengthen Partnership to Advance Continuous Tableting Technology
-
SPT Labtech to co-market streamlined NGS library preparation workflows for both PCR and PCR-free applications with Roche
-
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials
Mar 18, 2024
-
DNAnexus Adds NVIDIA NIM and CUDA-X Microservices to Precision Health Data Cloud to Accelerate Drug Discovery and Improve Patient Care
DNAnexus is integrating new NVIDIA NIM and CUDA-X microservices to its Precision Health Data Cloud.
Mar 18, 2024
-
Bio-IT World: Venture, Innovation & Partnering Conference to Debut in Boston, Concurrent with 23rd Annual Bio-IT World Conference & Expo
Cambridge Healthtech Institute announces the final agenda for the inaugural Bio-IT World: Venture, Innovation & Partnering Conference—a gathering of leading investors, executives, research institutions, biotech and informatics innovators, startups, and strategics whose creative partnerships are catalyzing today’s drug discoveries. The April 17 Boston event, drawing heavily from leaders within the renowned Boston/Cambridge, Mass. biotech community, will be part of the 23rd annual Bio-IT World Conference & Expo April 15-17, which will attract more than 3,000 life science and IT innovators.
Mar 18, 2024
-
AbbVie Launches Phase I Clinical Trial for ABBV-1882, Promising HIV Drugs Treatment Approach
The initiation of the phase I clinical trial for ABBV-1882 marks a significant milestone in the quest for novel HIV treatments. With its unique mechanism of action and potential to transform HIV management, ABBV-1882 represents a beacon of hope for individuals living with HIV and underscores AbbVie's unwavering commitment to advancing science for the benefit of patients worldwide.
Mar 19, 2024
-
Join Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024
Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.
Mar 18, 2024
-
Don't Miss: Huateng Pharma's Exhibit at CPHI Japan 2024
Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.
Mar 18, 2024
-
Alfa Chemistry Adds to Its Lineup of Derivatization Reagents for High-Performance Liquid Chromatography (HPLC)
-
CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies
-
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Mar 17, 2024